Products
16170 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Motors Constant Leverage with ISIN code: CH1423416242 | General Motors | Constant Leverage | Long | ― | 73.326 | 26.82 | 0.250 | 27.07 | 1 | -3.97% | -10.69% | -57.76% | 7 May. 2025 | |
| General Motors Constant Leverage with ISIN code: CH1450969139 | General Motors | Constant Leverage | Short | ― | 73.326 | 0.21 | 0.010 | 0.22 | 1 | 0.00% | 5.00% | 75.00% | 21 Aug. 2025 | |
| General Motors Constant Leverage with ISIN code: CH1362351459 | General Motors | Constant Leverage | Short | ― | 73.326 | 0.35 | 0.010 | 0.36 | 1 | 0.00% | 2.94% | 52.17% | 6 Nov. 2024 | |
| Genmab Constant Leverage with ISIN code: CH1119068364 | Genmab | Constant Leverage | Long | ― | 1,679.467 | 0.22 | 0.030 | 0.25 | 1 | -15.38% | -26.67% | -40.54% | 18 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1235293474 | Genmab | Constant Leverage | Long | ― | 1,679.467 | 0.083 | 0.003 | 0.086 | 1 | -7.78% | -17.00% | -40.71% | 10 Jan. 2023 | |
| Genmab Constant Leverage with ISIN code: CH1450969170 | Genmab | Constant Leverage | Long | ― | 1,679.467 | 5.78 | 0.120 | 5.9 | 1 | -9.69% | -27.66% | -53.08% | 21 Aug. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1450969451 | Genmab | Constant Leverage | Long | ― | 1,679.467 | 2.53 | 0.050 | 2.58 | 1 | -9.64% | -27.51% | -52.97% | 15 Sep. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1423417562 | Genmab | Constant Leverage | Long | ― | 1,679.467 | 1.7 | 0.050 | 1.75 | 1 | -13.27% | -35.85% | -65.02% | 13 Jun. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1396328994 | Genmab | Constant Leverage | Short | ― | 1,679.467 | 0.15 | 0.030 | 0.18 | 1 | -11.76% | 7.14% | 15.38% | 12 Feb. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1345999051 | Genmab | Constant Leverage | Short | ― | 1,679.467 | 0.43 | 0.030 | 0.46 | 1 | 0.00% | 19.44% | 34.38% | 18 Apr. 2024 | |
| Genmab Constant Leverage with ISIN code: CH1119068372 | Genmab | Constant Leverage | Short | ― | 1,679.467 | 0.69 | 0.030 | 0.72 | 1 | 1.47% | 15.00% | 27.78% | 18 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223048 | Gilead Sciences | Constant Leverage | Long | ― | 140.839 | 10.98 | 0.040 | 11.02 | 1 | -12.65% | -16.06% | -40.39% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223055 | Gilead Sciences | Constant Leverage | Long | ― | 140.839 | 0.93 | 0.010 | 0.94 | 1 | -17.70% | -21.85% | -51.56% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1119067762 | Gilead Sciences | Constant Leverage | Long | ― | 140.839 | 28.5 | 0.060 | 28.56 | 1 | -8.06% | -10.21% | -27.17% | 11 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968131 | Gilead Sciences | Constant Leverage | Short | ― | 140.839 | 0.5 | 0.010 | 0.51 | 1 | 11.11% | 16.28% | 38.89% | 9 Jul. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968149 | Gilead Sciences | Constant Leverage | Short | ― | 140.839 | 1.67 | 0.010 | 1.68 | 1 | 9.15% | 11.33% | 30.47% | 9 Jul. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1119066574 | Givaudan | Constant Leverage | Long | ― | 2,748.061 | 0.66 | 0.030 | 0.69 | 1 | -13.16% | -5.71% | -33.33% | 27 Apr. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1197221224 | Givaudan | Constant Leverage | Long | ― | 2,748.061 | 0.14 | 0.030 | 0.17 | 1 | -26.32% | -22.22% | -51.72% | 15 Jun. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1423416499 | Givaudan | Constant Leverage | Long | ― | 2,748.061 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -75.00% | 12 May. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1290994222 | Givaudan | Constant Leverage | Short | ― | 2,748.061 | 4.8 | 0.200 | 5 | 1 | 13.48% | -3.81% | 60.54% | 18 Apr. 2024 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.